Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial

Retail Investor Stocks

Retail investor stocks are shares frequently bought and sold by individual investors rather than institutional entities. These investors often trade through online brokerages and may focus on popular, high-profile companies or emerging market opportunities. Their collective activity can impact stock prices, liquidity, and market sentiment, making retail investor behavior a key factor in short-term market movements.

Retail Investor Stocks Recent News

OS Therapies Reports Strong Survival Data for Bone Cancer Treatment
OS Therapies Reports Strong Survival Data for Bone Cancer Treatment
OS Therapies (NYSE: OSTX) interim Phase 2b trial data shows a 71.2% 3-year overall survival rate for OST-HER2 vs. 45.8% for controls.
Why American Bitcoin (ABTC) Stock Is Sliding Friday
Why American Bitcoin (ABTC) Stock Is Sliding Friday
Shares of American Bitcoin are trading lower Friday, pulling back from Thursday’s rally amid digital-asset weakness after labor market data.
Modular Medical Secures National PBM Contract For Pivot Insulin Pump
Modular Medical Secures National PBM Contract For Pivot Insulin Pump
Modular Medical secured a national PBM contract to expand access to its Pivot tubeless insulin patch pump for patients managing diabetes.
Clearmind Medicine Stock Slides Friday: What's Happening?
Clearmind Medicine Stock Slides Friday: What's Happening?
Clearmind Medicine shares are trading lower Friday as investors weigh the biotech’s move to acquire a majority stake in an EV charging firm.
Aptevo Therapeutics Reports 93% Clinical Benefit Rate in Key Leukemia Trial
Aptevo Therapeutics Reports 93% Clinical Benefit Rate in Key Leukemia Trial
Aptevo Therapeutics announced a 93% clinical benefit rate for mipletamig in frontline acute myeloid leukemia trial results.
Medicus Pharma Inks Global Licensing Deal with Pfizer Worth Over $1 Billion
Medicus Pharma Inks Global Licensing Deal with Pfizer Worth Over $1 Billion
Medicus Pharma partners with Pfizer to commercialize CD228V in a licensing deal worth over $1 billion plus royalties.
Farmmi Stock Skyrockets Wednesday: What's Happening?
Farmmi Stock Skyrockets Wednesday: What's Happening?
Shares of Farmmi are soaring Wednesday afternoon, despite persistent liquidity concerns and the ongoing threat of delisting from the Nasdaq.
Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study
Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study
Can-Fite BioPharma reports longer survival in its Phase 3 liver cancer trial and raises $4 million through a warrant exercise.
BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening?
BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening?
bioAffinity Technologies is surging Wednesday as traders digest recent commercial expansion news alongside tight low-float trading dynamics.
BioAffinity Advances Noninvasive CyPath Lung Test For Post-Treatment Monitoring
BioAffinity Advances Noninvasive CyPath Lung Test For Post-Treatment Monitoring
bioAffinity stock trades higher as it advances its CyPath Lung test for post-treatment lung cancer surveillance.
Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?
Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?
MIRA Pharmaceuticals (NASDAQ: MIRA) stock jumps as MIRA-55 meets key preclinical study milestones for non-opioid inflammatory pain relief.
Core AI Holdings Stock Surges Following Q2 Results and Infrastructure Expansion
Core AI Holdings Stock Surges Following Q2 Results and Infrastructure Expansion
Core AI Holdings is surging Friday after it reported strong Q2 revenue growth, improved margins, and increased operating cash flow.
FingerMotion Stock Skyrockets on Strategic Pivot To AI Data Center Expansion
FingerMotion Stock Skyrockets on Strategic Pivot To AI Data Center Expansion
FingerMotion is surging Friday after updates on new management's pivot into AI and high-performance computing across North America.
Nano Labs Stock Falls Friday as Market Digests H1 Net Loss, AI Pivot
Nano Labs Stock Falls Friday as Market Digests H1 Net Loss, AI Pivot
Nano Labs is trading lower Friday after its H1 2026 results, as investors weigh a wider net loss against a pivot to AI hardware and crypto.
Why Is Celularity Stock Gaining Thursday?
Why Is Celularity Stock Gaining Thursday?
Celularity (CELU) stock surged 131% following a $300M U.S. manufacturing collaboration with MuseCell Innovations in New Jersey.
Beam Global Stock Rallies Wednesday: What's Going On?
Beam Global Stock Rallies Wednesday: What's Going On?
Beam Global shares are surging Wednesday despite no company-specific news, after last week's Q2 beat and growth in drone, defense and AI.
YY Group Holding (YYGH) Stock Surges Wednesday: What's Happening?
YY Group Holding (YYGH) Stock Surges Wednesday: What's Happening?
Shares of YY Group are trading sharply higher Wednesday afternoon after the company took steps to eliminate future equity overhangs.
Rezolve AI Stock Climbs Tuesday: What's Driving the Action?
Rezolve AI Stock Climbs Tuesday: What's Driving the Action?
Shares of Rezolve AI Ltd. are rising Tuesday morning following a major enterprise technology validation. Here's what investors need to know.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved